Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication.

Foss, F M

Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication. [electronic resource] - Clinical lymphoma Mar 2001 - 298-302 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study

1526-9655

10.3816/clm.2001.n.005 doi


Adult
Aged
Aged, 80 and over
Combined Modality Therapy
Dexamethasone--therapeutic use
Diphtheria Toxin--adverse effects
Drug Hypersensitivity--etiology
Female
Glucocorticoids--therapeutic use
Humans
Immunosuppressive Agents--adverse effects
Immunotoxins--adverse effects
Interleukin-2--adverse effects
Lymphocytes--immunology
Lymphoma, T-Cell, Cutaneous--drug therapy
Male
Middle Aged
Neoplasm Staging
Prednisone--therapeutic use
Premedication
Recombinant Fusion Proteins--adverse effects
Skin Neoplasms--drug therapy
Syndrome
Treatment Outcome